Castration-Resistant Prostate Carcinoma

Showing 1 - 25 of 55

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Seattle

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • Biopsy
  • +9 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Nov 17, 2023

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Seattle

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • Biopsy
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 8, 2023

Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Apalutamide, Biopsy, Biospecimen Collection)

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • Prostate Adenocarcinoma
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 20, 2023

Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Stage IVB Prostate Cancer AJCC v8 Trial in San

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Jun 20, 2023

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Duarte

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • Autologous Anti-PSCA-CAR-4-1BB/TCRzeta-CD19t-expressing T-lymphocytes
  • +7 more
  • Duarte, California
    City of Hope Medical Center
Apr 5, 2023

Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Scottsdale, Jacksonville, Rochester

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • Stage IVB Prostate Cancer AJCC v8
  • Biopsy
  • +7 more
  • Scottsdale, Arizona
  • +2 more
Feb 15, 2023

Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Lymph Nodes, Metastatic Prostate Carcinoma Trial in

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +3 more
  • Los Angeles, California
  • +22 more
Feb 2, 2023

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • Abiraterone Acetate/Niraparib
  • +5 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Jan 9, 2023

68Ga-PSMA-11 PET/CT Screening Prior to 177Lu-PSMA-617 Therapy

Enrolling by invitation
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • Computed Tomography
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 16, 2023

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial in United States

Active, not recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • Duarte, California
  • +22 more
Jan 3, 2023

Advanced Pancreatic Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8 Trial in

Recruiting
  • Advanced Pancreatic Carcinoma
  • +27 more
  • Gainesville, Florida
  • +3 more
Jan 3, 2023

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial in San Francisco

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +4 more
  • Computed Tomography
  • +3 more
  • San Francisco, California
    University of California San Francisco
Dec 19, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in United

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • Laboratory Biomarker Analysis
  • +3 more
  • La Jolla, California
  • +21 more
Dec 2, 2022

Melanoma, Breast Carcinoma, Hepatocellular Carcinoma Trial in United States (XmAb20717)

Completed
  • Melanoma
  • +27 more
  • XmAb20717
  • Los Angeles, California
  • +16 more
Nov 29, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Prostate Adenocarcinoma Trial in

Active, not recruiting
  • Castration-Resistant Prostate Carcinoma
  • +5 more
  • Questionnaire Administration
  • Tin Sn 117m Pentetate
  • Lexington, Kentucky
    University of Kentucky/Markey Cancer Center
Nov 26, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Prostate Adenocarcinoma Trial in Houston

Completed
  • Castration-Resistant Prostate Carcinoma
  • +5 more
  • Durvalumab
  • Tremelimumab
  • Houston, Texas
    M D Anderson Cancer Center
Nov 9, 2022

National Cancer Institute "Cancer Moonshot Biobank"

Recruiting
  • Acute Myeloid Leukemia
  • +33 more
  • Biospecimen Collection
  • Medical Chart Review
  • Kingman, Arizona
  • +99 more
Nov 3, 2022

Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Laboratory Biomarker Analysis, Olaparib,

Active, not recruiting
  • Castration-Resistant Prostate Carcinoma
  • Prostate Adenocarcinoma
  • Laboratory Biomarker Analysis
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 19, 2022

Castration-Resistant Prostate Carcinoma, Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +7 more
  • Biopsy
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 12, 2022

Castration-Resistant Prostate Carcinoma, Hormone-Resistant Prostate Cancer, PSA Progression Trial in Portland (drug, other,

Active, not recruiting
  • Castration-Resistant Prostate Carcinoma
  • +4 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Sep 26, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer American Joint Committee on

Terminated
  • Castration-Resistant Prostate Carcinoma
  • +4 more
  • Computed Tomography
  • +2 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Sep 19, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Tumor in the Soft Tissues

Active, not recruiting
  • Castration-Resistant Prostate Carcinoma
  • +6 more
  • San Francisco, California
  • +1 more
Sep 20, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in San

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +6 more
  • San Francisco, California
    University of California, San Francisco
Sep 8, 2022

Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in Detroit,

Active, not recruiting
  • Castration Levels of Testosterone
  • +4 more
  • Detroit, Michigan
  • +1 more
Aug 30, 2022

Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Olaparib)

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • Prostate Adenocarcinoma
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 23, 2022